All articles by Refna Tharayil
Refna Tharayil
Ataraxis AI to transform precision medicine in cancer care with $20.4m Series A
The round also received backing from angel investors and healthcare pioneers, including Mario Schlosser, co-founder and former CEO of Oscar Health (NYSE: OSCR), Ryan Fukushima, COO of Tempus, and others
BlueSleep and Moona Health announce clinical partnership to enhance sleep treatment options
This collaboration brings together two telehealth clinical leaders in sleep health to provide comprehensive, accessible care pathways for patients
Bluenote secures $10m to enhance AI capabilities in life sciences
The company’s AI platform streamlines workflows for life sciences, supporting tasks like regulatory filings, technical reports, and SOPs
Zai Lab and Innoviva get Chinese approval for Xacduro in HABP/VABP
The approval was based on the positive results from Phase 3 ATTACK trial in which Xacduro proved its statistical non-inferiority to colistin regarding the primary endpoint of 28-day all-cause mortality